These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34462525)

  • 41. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
    Blair A; Sutherland HJ
    Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
    Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
    Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
    Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
    Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
    Goardon N; Marchi E; Atzberger A; Quek L; Schuh A; Soneji S; Woll P; Mead A; Alford KA; Rout R; Chaudhury S; Gilkes A; Knapper S; Beldjord K; Begum S; Rose S; Geddes N; Griffiths M; Standen G; Sternberg A; Cavenagh J; Hunter H; Bowen D; Killick S; Robinson L; Price A; Macintyre E; Virgo P; Burnett A; Craddock C; Enver T; Jacobsen SE; Porcher C; Vyas P
    Cancer Cell; 2011 Jan; 19(1):138-52. PubMed ID: 21251617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.
    Si X; Zhang X; Hao X; Li Y; Chen Z; Ding Y; Shi H; Bai J; Gao Y; Cheng T; Yang FC; Zhou Y
    Oncotarget; 2016 Nov; 7(47):78095-78109. PubMed ID: 27801668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The JmjC-domain protein NO66/RIOX-1 affects the balance between proliferation and maturation in acute myeloid leukemia.
    Yu W; Lutz C; Krämer A; Schmidt-Zachmann MS
    Exp Cell Res; 2021 May; 402(1):112566. PubMed ID: 33745927
    [TBL] [Abstract][Full Text] [Related]  

  • 47. AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.
    Fan D; Li Z; Zhang X; Yang Y; Yuan X; Zhang X; Yang M; Zhang Y; Xiong D
    J Hematol Oncol; 2015 Feb; 8():18. PubMed ID: 25879549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoids Inhibit Oncogenic RUNX1-ETO in Acute Myeloid Leukemia with Chromosome Translocation t(8;21).
    Lu L; Wen Y; Yao Y; Chen F; Wang G; Wu F; Wu J; Narayanan P; Redell M; Mo Q; Song Y
    Theranostics; 2018; 8(8):2189-2201. PubMed ID: 29721072
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MUC1 is a potential target for the treatment of acute myeloid leukemia stem cells.
    Stroopinsky D; Rosenblatt J; Ito K; Mills H; Yin L; Rajabi H; Vasir B; Kufe T; Luptakova K; Arnason J; Nardella C; Levine JD; Joyce RM; Galinsky I; Reiter Y; Stone RM; Pandolfi PP; Kufe D; Avigan D
    Cancer Res; 2013 Sep; 73(17):5569-79. PubMed ID: 23867470
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia.
    Pan R; Ruvolo VR; Wei J; Konopleva M; Reed JC; Pellecchia M; Andreeff M; Ruvolo PP
    Blood; 2015 Jul; 126(3):363-72. PubMed ID: 26045609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.
    Larrue C; Mouche S; Angelino P; Sajot M; Birsen R; Kosmider O; Mckee T; Vergez F; Recher C; Mas VM; Gu Q; Xu J; Tsantoulis P; Sarry JE; Tamburini J
    Sci Transl Med; 2024 Jul; 16(757):eadk1731. PubMed ID: 39047119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Live kinase B1 maintains CD34
    Wang H; Wang X; Xin N; Qi L; Liao A; Yang W; Liu Z; Zhao C
    Mol Cell Biochem; 2017 Oct; 434(1-2):25-32. PubMed ID: 28397012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia.
    Boudreaux SP; Duren RP; Call SG; Nguyen L; Freire PR; Narayanan P; Redell MS; Conneely OM
    Leukemia; 2019 Jan; 33(1):52-63. PubMed ID: 29884904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of TLR8 signaling in acute myeloid leukemia differentiation.
    Ignatz-Hoover JJ; Wang H; Moreton SA; Chakrabarti A; Agarwal MK; Sun K; Gupta K; Wald DN
    Leukemia; 2015 Apr; 29(4):918-926. PubMed ID: 25283842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hsa-circ_0003420 induces apoptosis in acute myeloid leukemia stem cells and impairs stem cell properties.
    Lin G; Fei Y; Zhang Y
    Immunopharmacol Immunotoxicol; 2021 Oct; 43(5):622-631. PubMed ID: 34477035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sphingosine-1 phosphate receptor 1 (S1PR1) expression maintains stemness of acute myeloid leukemia stem cells.
    Wang YQ; Ren Y; Gale RP; Niu LT; Huang XJ
    Cancer Lett; 2024 Sep; 600():217158. PubMed ID: 39111385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia.
    Goldberg L; Tijssen MR; Birger Y; Hannah RL; Kinston SJ; Schütte J; Beck D; Knezevic K; Schiby G; Jacob-Hirsch J; Biran A; Kloog Y; Marcucci G; Bloomfield CD; Aplan PD; Pimanda JE; Göttgens B; Izraeli S
    Blood; 2013 Oct; 122(15):2694-703. PubMed ID: 23974202
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
    Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.